SAiGENCI Annual Public Lecture - Decoding Cancer: How epigenetics could solve the cancer riddle
- Date: Tue, 21 May 2024, 5:30 pm - 6:30 pm
- Location: The Braggs Lecture Theatre
- Cost: Free
- More information: SAiGENCI Public Lecture
- Professor Jose Polo Professor of Epigenetics, Director of the Adelaide Centre for Epigenetics (ACE) and Program Lead, Cancer Epigenetics with SAiGENCI
- Dr Adrienne Sullivan Head of the Development and Epigenetics Laboratory at the Adelaide Centre for Epigenetics and Cancer Epigenetics program at SAiGENCI.
Join us for an engaging lecture to unravel the mysteries of cancer. In this eye-opening session, our experts will unveil the fascinating connection between cancer and epigenetics. Epigenetic 'marks' are small changes within the genomes in our DNA that control which genes are expressed by different cells. Learn how these tiny molecular signatures can decide the fate of cells, shaping the onset and progression of cancer.
From learning about epigenetics and its role in tumour development to exploring groundbreaking research, this lecture promises to ignite your curiosity and empower you with new understanding.
There will be an opportunity to ask questions. Light refreshments will be served after the lecture, giving you an opportunity to meet the speakers and our cancer research team.
Professor Jose Polo
Professor of Epigenetics and Director of the Adelaide Centre for Epigenetics (ACE) and Program Lead at SAiGENCI in the Faculty of Health and Medical Sciences at the University of Adelaide. Jose worked at the Harvard Stem Cell Institute before establishing his own successful research group at Monash University. His pivotal work in epigenetics, embryogenesis and cancer continues to earn accolades and international recognition.
Dr Adrienne Sullivan
Head of the Development and Epigenetics Lab at the Adelaide Centre for Epigenetics and the Cancer Epigenetics program at SAiGENCi. Formerly a Rutherford-Crick Fellow at the Francis Crick Institute, UK, Adrienne’s work is critical in advancing our understanding of cancer drivers and epigenetic mechanisms. Currently, she is investigating a major gene associated with breast cancer progression.